Apidra
Drug timelines are a Plus or Pro feature.
45 regulatory and trial events tracked for Apidra, covering 2007-04-12 to 2026-03-05. Get the full timeline:
Most recent: EMA Authorised: Apidra (insulin glulisine) — sanofi-aventis Deutschland GmbH